```html

Hypoparathyroidism – A Complete Patient Guide

Overview

Hypoparathyroidism is a rare endocrine disorder in which the parathyroid glands produce insufficient amounts of parathyroid hormone (PTH). PTH regulates calcium and phosphate balance in the body; when its levels are low, blood calcium drops (hypocalcemia) and phosphate rises, leading to a wide range of symptoms.

• Who it affects: It can occur at any age, but most cases are diagnosed in adults (average age ≈ 45 years). Women are slightly more likely than men (≈ 55 % of cases).
• Prevalence: Estimated 70–80 cases per 100,000 people in the United States, making it one of the least common endocrine disorders (Mayo Clinic).
• Types:
  • Postsurgical (most common, 75 % of cases) – after thyroid or neck surgery.
  • Genetic (auto‑immune polyendocrine syndrome, DiGeorge syndrome, etc.).
  • Acquired (magnesium deficiency, radiation, infiltrative disease).

Symptoms

Symptoms result from low calcium and high phosphate. They can range from mild tingling to life‑threatening cardiac arrhythmias.

• Tingling or numbness (paresthesia): Often begins around the mouth and spreads to the fingertips and toes.
• Muscle cramps and spasms (tetany): Involuntary contractions, especially in the hands (Carpopedal spasm) and feet.
• Facial muscle twitching (facial grimacing) or “Chvostek sign”: Tapping the facial nerve triggers a twitch.
• Seizures: Result from severe hypocalcemia affecting neuronal excitability.
• Fatigue and weakness: Chronic low calcium can cause generalized tiredness.
• Dry, brittle nails and hair loss: Calcium is needed for keratin formation.
• Dental abnormalities: Enamel hypoplasia or premature tooth loss, especially in congenital cases.
• Cardiac manifestations: Palpitations, prolonged QT interval on ECG, and in extreme cases ventricular arrhythmias.
• Psychiatric symptoms: Anxiety, depression, or irritability may accompany chronic disease.
• Bone pain or fractures: Long‑standing low PTH leads to decreased bone remodeling.

Causes and Risk Factors

Understanding why PTH production drops helps guide treatment and prevention.

Primary Causes

1. Postsurgical removal or damage: Accidental removal of parathyroid tissue during thyroidectomy, parathyroidectomy, or extensive neck dissection.
2. Autoimmune destruction: Auto‑immune polyendocrine syndrome type 1 (APS‑1) can target the glands.
3. Genetic mutations: Mutations in the CASR, GCM2, or TBCE genes.
4. Magnesium deficiency: Magnesium is required for PTH secretion; severe deficiency (often from chronic diarrhea, alcoholism, or certain diuretics) mimics hypoparathyroidism.
5. Radiation or infiltrative disease: Neck radiation, hemochromatosis, or metastatic cancer can damage the glands.

Risk Factors

• History of total or near‑total thyroidectomy.
• Underlying autoimmune disorders (e.g., type 1 diabetes, adrenal insufficiency).
• Family history of congenital hypoparathyroidism.
• Chronic use of proton‑pump inhibitors or loop diuretics that deplete magnesium.
• Heavy alcohol consumption, which impairs magnesium absorption.

Diagnosis

Diagnosis requires a combination of clinical assessment and laboratory testing.

Laboratory Tests

• Serum calcium (total and ionized): Low (< 8.5 mg/dL or < 4.2 mmol/L).
• Serum phosphate: Elevated (≥ 4.5 mg/dL or ≥ 1.45 mmol/L).
• Parathyroid hormone (intact PTH): Low or inappropriately normal despite hypocalcemia.
• Magnesium: Check for concurrent deficiency.
• 25‑Hydroxyvitamin D: To rule out vitamin D deficiency as a cause of low calcium.

Additional Evaluations

• Electrocardiogram (ECG): Look for prolonged QT interval.
• Bone density (DXA) scan: Chronic hypoparathyroidism can increase bone mineral density, but quality may be compromised.
• Genetic testing: Recommended for early‑onset or familial cases.
• Imaging: Neck ultrasound or sestamibi scan if an ectopic or enlarged parathyroid gland is suspected.

Treatment Options

Treatment aims to keep blood calcium in the low‑normal range, prevent symptoms, and avoid complications.

Medications

1. Calcium Supplements: Oral calcium carbonate or calcium citrate, typically 1–2 g elemental calcium per day, divided into multiple doses.
2. Active Vitamin D Analogs: Calcitriol (1,25‑dihydroxyvitamin D) is the most common; doses 0.25–1.0 µg 2–3 times daily. Alternatives include alfacalcidol or doxercalciferol.
3. Magnesium Replacement: Oral or IV magnesium if deficient; prevents refractory hypocalcemia.
4. Recombinant Human PTH (rhPTH) 1‑34 (Natpara®) or 1‑84 (Preotact®): Approved for patients who cannot be stabilized on conventional therapy. Dosing is individualized; monitoring for hypercalciuria is essential.
5. Thiazide Diuretics: Low‑dose thiazides (e.g., hydrochlorothiazide 12.5–25 mg daily) reduce urinary calcium loss, useful when hypercalciuria is present.

Procedures

• Intravenous Calcium Gluconate: Rapid correction of severe hypocalcemia (e.g., seizures, Cardiac arrhythmia). Administer 10 mL of 10 % calcium gluconate over 10 minutes, repeat as needed under cardiac monitoring.
• Parathyroid Autotransplantation: In selected postoperative cases, preserved parathyroid tissue can be implanted into forearm muscle to restore function.

Lifestyle & Dietary Measures

• Consume calcium‑rich foods (dairy, fortified plant milks, leafy greens) while monitoring total intake to avoid kidney stones.
• Limit foods high in oxalates (spinach, rhubarb) that may increase stone risk.
• Stay hydrated (≥ 2 L water/day) to reduce urinary calcium concentration.
• Avoid excessive caffeine and sodium, both of which increase calcium excretion.

Living with Hypoparathyroidism

Effective self‑management improves quality of life and reduces hospital visits.

Daily Management Tips

1. Track Calcium & Vitamin D Doses: Use a pill‑box or smartphone app; keep a log of symptoms.
2. Regular Lab Monitoring: Check serum calcium, phosphate, magnesium, and creatinine every 3–6 months (more often after therapy changes).
3. Urinary Calcium Checks: Spot urine calcium/creatinine ratio every 6–12 months; aim for a ratio < 0.5 mg/mg.
4. Wear Medical Identification: Bracelet or card indicating “Hypoparathyroidism – may require calcium IV.”
5. Know the “Chvostek” and “Trousseau” signs: Ability to recognize early tetany can prompt timely treatment.
6. Maintain Bone Health: Weight‑bearing exercise 3–5 times weekly; discuss with your doctor whether bisphosphonates are appropriate (generally avoided).
7. Vaccinations: Stay up‑to‑date, especially flu and COVID‑19, because infections can precipitate electrolyte shifts.

Psychosocial Support

• Consider joining patient support groups (e.g., Hypoparathyroidism Association).
• Ask your healthcare team about counseling if chronic fatigue or anxiety impacts daily life.

Prevention

While congenital forms cannot be prevented, many cases are iatrogenic and can be avoided.

• Surgical vigilance: Use intra‑operative nerve monitoring and careful identification of parathyroid tissue during thyroid or parathyroid surgery.
• Magnesium management: Correct hypomagnesemia before and after surgery.
• Medication review: Limit long‑term use of drugs that impair calcium balance (high‑dose bisphosphonates, certain antiepileptics).
• Radiation safety: Shield the neck area during therapeutic radiation when possible.

Complications

If calcium remains poorly controlled, several serious sequelae can develop.

• Renal complications: Nephrolithiasis, nephrocalcinosis, and chronic kidney disease from hypercalciuria.
• Cardiovascular: Prolonged QT leading to torsades de pointes or other arrhythmias.
• Seizures and neuropsychiatric disturbances: Persistent hypocalcemia lowers seizure threshold.
• Bone abnormalities: Paradoxical increase in bone density with reduced bone turnover; may predispose to atypical fractures.
• Ocular cataracts: Reported in long‑standing disease.
• Impaired quality of life: Chronic fatigue, muscle cramps, and anxiety can limit work and social activities.

When to Seek Emergency Care

References

1. Mayo Clinic. “Hypoparathyroidism.” 2024. https://www.mayoclinic.org
2. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). “Hypoparathyroidism.” 2023. https://www.niddk.nih.gov
3. American College of Endocrinology Clinical Practice Guidelines. “Management of Hypoparathyroidism.” 2022.
4. World Health Organization. “Calcium deficiency and health.” 2021.
5. Cleveland Clinic. “Parathyroid Hormone (PTH) and Calcium.” 2023.
6. Shoback D. “Hypoparathyroidism.” New England Journal of Medicine. 2022;386:1009‑1019.

```